why are glp-1 medications so expensive National Academy of Medicine | changing the conversation about obesity, but what does the evidence really say? Drugs like Ozempic, Wegovy, and Long-term Success of GLP-1s Hinges

Some people notice changes within a few weeks, while for others it takes a bit longer

Despite the regained weight, the study suggests that approximately 25 % of the weight loss acutely stays off over time

For example, Wegovy is approved for chronic weight management in adolescents ages 12 and older who meet certain medical criteria, including obesity

The demand for GLP1-RA approved for obesity is high so there have even been supply shortages in Europe

Regional Analysis North America Leading the GLP-1 Receptor Agonist Market North America accounted for the largest revenue share of 49.7% , supported by the high prevalence of type 2 diabetes and obesity, a developed healthcare system, and favorable reimbursement structures